Į-catulin is oncoprotein that help sustains proliferation by preventing cellular senescence. Here we report that Į-catulin also drives malignant invasion and metastasis. Į-catulin was upregulated in highly invasive non-small cell lung cancer PRÉCIS: Findings reveal a novel signaling axis of invasion and metastasis in lung adenocarcinoma that offers therapeutic targets to treat this aggressive disease.
associated with the migratory and invasive abilities of cancer cells.
Į-Catulin enhances lung cancer cell metastasis in vivo
To investigate whether Į-catulin can enhance lung cancer cell metastasis in vivo, we generated lung tumor metastasis models by subcutaneously injecting control, Į-catulin-overexpressing CL1-0, or Į-catulin knockdown CL1-5 cells into non-obese diabetic (NOD)-severe combined immunodeficiency (SCID) mice and measured the number of lung nodule formations ( Fig. 2A) . Following subcutaneous injection, the Į-catulin-overexpressing cells induced a similar incidence of tumor formation compared to the controls, with each group having 4 tumors resulting from a total of 4 inoculations. Interestingly, twelve weeks after subcutaneous injection, the mice that were injected with Į-catulin-overexpressing cells displayed a significantly elevated incidence of metastatic tumors in the lung compared with the controls (Fig. 2B and C).
At this time point, the mice that were injected with Į-catulin-overexpressing cells had larger tumors than the mice that were injected with control cells (Supplementary Fig.   S2A ). In contrast, we found that the mice that were subcutaneously injected with the shC01-infected CL1-5 cells had a significantly decreased number of lung nodules compared to those injected with the shLuci-infected control cells (Fig. 2D ). The incidence of tumor formation from shC01-infected CL1-5 cells was similar to the incidence in the control cells, with each group having 8 tumors resulting from a total of 10 inoculations. However, the average tumor size in the mice injected with the shC01-infected CL1-5 cells was notably smaller (Supplementary Fig. S2B ). We also evaluated the metastatic potential for lung colonization following tail vein injections ( Į-catulin-overexpressing cells (Fig. 2F ) and significantly decreased in the mice inoculated with the Į-catulin-depleted cells ( Fig. 2G and H) . The average lung weight from the mice that were injected with the shC01-infected CL1-5 cells also decreased compared to the lungs from the control mice that were injected with the shLuci-infected CL1-5 cells (Supplementary Fig. S2C ). This series of assays demonstrated that by increasing the migratory and invasive behavior of lung cancer cells, Į-catulin promoted cancer cell metastasis in vivo.
Į-Catulin enhances lung cancer cell migration and invasion through interaction with ILK
To dissect the mechanism of action of Į-catulin in cancer cell migration and invasion, we carried out a yeast-two hybrid screen using full-length Į-catulin as bait to identify its interaction partners. One of the key interacting proteins that we identified was integrin-linked kinase (ILK) (Fig. 3A) . To confirm the binding of ILK to Į-catulin, protein lysates were immunoprecipitated with anti-Į-catulin or anti-ILK antibodies and then visualized by Western blotting. The results demonstrated that endogenous Į-catulin could interact with ILK (Fig. 3B) . Next, we wanted to determine which domain of ILK interacted with Į-catulin. Deletion mutants of FLAG-ILK (Fig. 3C ) and full-length Į-catulin-GFP were cotransfected into CL1-0 cells, and the protein lysates were immunoprecipitated with an anti-FLAG antibody and visualized by Western blotting with an anti-Į-catulin antibody. As shown in Figure 3D , the full-length and the 1-170 amino acid region of ILK interacted with Į-catulin. ILK has been found to play an important role in inducing the epithelial-mesenchymal transition and in promoting cancer cell migration and invasion (18). We also found that the protein expression level of ILK ranges from low in CL1-0 to high in CL1-5. (Supplementary Fig. S3 ). Thus, we wanted to test whether the interaction between ILK and Į-catulin mediated Į-catulin-driven cancer cell migration and invasion. We used specific shRNAs to silence ILK expression in Į-catulin-overexpressing CL1-0 cells (Supplementary Fig.   S4A ). These cells were assayed for migration and invasion using a Transwell system.
The results revealed that Į-catulin overexpressing CL1-0 cells exhibited increased cell migration and invasion, and depletion of ILK expression diminished this phenomenon (Fig. 3E) . Surprisingly, we found that Į-catulin also plays a key role in ILK-mediated cancer cell migration and invasion. We knocked down the expression of Į-catulin in ILK overexpressing CL1-5 cells, which led to a decrease in the migratory/invasive ability induced by ILK expression (Fig. 3F, Supplementary Fig.   S4B ).
Į-Catulin-promoted activation of the Akt-NF-țB signaling pathway is ILK dependent
Previous studies have shown that Akt Ser473 could be directly phosphorylated by ILK, which results in Akt activation (14) . Activation of Akt leads to IțB-Į degradation and activates the NF-țB signaling pathway. Thus, we sought to elucidate whether the Akt-NF-țB signaling pathway is involved in Į-catulin-regulated cancer cell migration and invasion. As shown in Figure 4A , compared with the control cells, overexpression of Į-catulin in the CL1-0 cells dramatically increased the phosphorylation of Akt at Ser473, IțB-Į at Ser32 and NF-țB at Ser536. IțB is an inhibitor of NF-țB activation.
The phosphorylation of IțB-Į at Ser32 is required for its degradation, which in turn leads to the phosphorylation of NF-țB at Ser536 and promotes NF-țB translocation into the nucleus (23). Conversely, when we silenced Į-catulin expression in the CL1-5 cells, the phosphorylation of Akt at Ser473, IțB-Į at Ser32 and NF-țB at Ser536 decreased ( Fig. 4B) . Knockdown of ILK in the Į-catulin overexpressing cells diminished Į-catulin-induced NF-țB activation (Fig. 4C) . Interestingly, knockdown of Į-catulin in the ILK overexpressing cells also inhibited the activation of the Akt-NF-țB signaling pathway (Fig. 4D) . Next, we wanted to test whether NF-țB activation was involved in Į-catulin-induced cancer cell migration and invasion. We used an IțB kinase inhibitor, Bay 11-7082, to treat the Į-catulin overexpressing cells and found that inhibition of NF-țB effectively decreased Į-catulin-induced cell migration and invasion (Fig. 4E ).
Į-Catulin activates an integrin-ILK-NF-țB positive feedback loop to promote cell migration and invasion
To identify the molecular mechanisms by which Į-catulin affects cancer cell migration and invasion, we used a cDNA microarray to analyze the genes regulated by overexpression of Į-catulin. A MetaCore software analysis of global genes revealed that cytoskeleton remodeling was the major pathway that was significantly altered in the Į-catulin overexpressing cells (Fig. 5A ). Several genes involved in the reorganization of the cytoskeleton were markedly upregulated in the Į-catulin overexpressing cells (Fig 5B) . In addition, many NF-țB target genes were also increased in the Į-catulin overexpressing cells, suggesting that Į-catulin indeed activates the NF-țB pathway (Supplementary Table S1 ). The main function of ILK is to connect integrins to the cytoskeleton and to regulate cell-extracellular matrix (ECM) interactions, cytoskeletal organization and cell signaling, with important roles in cancer metastasis (11, 24) . Interestingly, we found that the ECM-integrin-ILK-GTPase signaling pathway, including fibronectin 1 (FN1), type IV collagen, integrins, cdc42 and ROCKs, is the predominant axis that is altered in Į-catulin overexpressing cells. and low-risk groups in the Michigan cohort were separable and showed a significant poor survival rate only in the group exhibiting both high levels of ILK and CTNNAL1 (log rank test, p= 0.019) ( structural module that connects integrins to the actin cytoskeleton, and it can also act as a signaling platform that modulates various cellular processes, including cell migration (11) . ILK is a central component for the assembly of the IPP complex, and it contributes both its adaptor properties and its kinase activity to directly activate several signaling pathways downstream of the integrins (12) . Here, we found that Į-catulin interacted with multiple ankyrin (ANK) repeat domains of ILK that are required for ILK localization to focal adhesions and for ILK signaling. The interaction between Į-catulin and ILK enhanced the phosphorylation of Akt at Ser473.
Knockdown of Į-catulin or ILK decreased Akt activation. Previous studies have demonstrated that the ANK domain of ILK also interacts with PINCH1 (28) and the

ILK-associated protein (ILKAP) (29). Deletion of the ANK domain of ILK or knockdown of PINCH1 expression could disrupt ILK localization to focal adhesions and decrease Akt Ser473 phosphorylation (30). ILKAP is a type-2C protein phosphatase that binds
to ILK and negatively regulates ILK signaling. These observations support the idea that ILK activity can be regulated by protein-protein interactions. In addition, Į-catulin is considered to be a cytoskeletal linker protein (6) due to its structural similarity to vinculin, which links the actin cytoskeleton to integrins (31). These results suggest that Į-catulin is an integrin signaling adaptor and plays a critical role in regulating integrin-mediated cellular functions via binding to ILK.
In addition to serving as the adaptor connecting integrin to the actin cytoskeleton, ILK is also a serine/threonine protein kinase. Glycogen synthase kinase 3ȕ (GSK-3ȕ) and Akt are the two major downstream substrates of ILK in cancer cells (32). ILK directly phosphorylates GSK-3ȕ at Ser9 and induces the dissociation of GSK-3ȕ from its substrate ȕ-catenin, leading to the stabilization and activation of ȕ-catenin (33). ILK also activates Akt through phosphorylation of Akt at Ser473, which regulates genes essential for survival, proliferation and migration (16, 34 Table S3 ). Taken together, Į-catulin may promote tumor growth in vivo by enhancing tumor angiogenesis.
upregulated in Į-catulin overexpressing cells (Supplementary
In conclusion, our data strongly suggest that the Į-catulin/ILK/NF-țB/integrin Į V ȕ 3 signaling pathway is associated with cell migration and invasion in NSCLC.
Fibronectin and integrin Į V ȕ 3 may regulate the activity of Į-catulin and ILK in a positive feedback loop. Thus, this novel signaling axis may be a potential therapeutic target for treating NSCLC metastasis. 
The number of lung metastatic nodules in individual mice was counted under a dissection microscope after 35 days. H, representative images of metastatic lung nodules (upper) and histological staining (H&E) of lung sections from mice injected with control (sh-Luci) or Į-catulin-depleted CL1-5 (sh-C01) cells. 
